background: radiodine therapy (rit) for hyperthyroidism is increasingly used as a therapy of choice in most of the patients. effect of multiple factors on the result of therapy was noted. this study tries to analyze the effect of multiple factors on success rate of rit. methods and patients: one hundred and sixty four hyperthyroid patients referred for rit therapy from 1996-99, were studied. th...

Background: Radiodine therapy (RIT) for hyperthyroidism is increasingly used as a therapy of choice in most of the patients. Effect of multiple factors on the result of therapy was noted. This study tries to analyze the effect of multiple factors on success rate of RIT. Methods and patients: One hundred and sixty four hyperthyroid patients referred for RIT therapy from 1996-99, were studi...

This analysis was performed to determine the effect of initial therapy on the outcomes of thyroid cancer patients. The study setting was a prospectively followed multi-institutional registry. Patients were stratified as low risk (stages I and II) or high risk (stages III and IV). Treatments employed included near-total thyroidectomy, administration of radioactive iodine, and thyroid hormone sup...

background: radiodine therapy (rit) for hyperthyroidism is increasingly used as a therapy of choice in most of the patients. effect of multiple factors on the result of therapy was noted. this study tries to analyze the effect of multiple factors on success rate of rit. methods and patients: one hundred and sixty four hyperthyroid patients referred for rit therapy from 1996-99, were studied. th...

background: this study aimed to assess several biochemical and oxidative stress parameters before and after radioiodine therapy in patients with well-differentiated thyroid cancer who consumed a low iodine diet and withdrawal of levothyroxine after total thyroidectomy. methods: we enrolled 40 candidates for radioiodine therapy. blood sampling was performed prior to as well as 72 h after consump...

Immunotherapy and targeted therapy are alternative treatments to differentiated thyroid cancer (DTC), which is usually treated with surgery radioactive iodine. However, in advanced carcinomas, molecular alterations can cause a progressive loss of iodine sensitivity, thereby making resistant iodine-refractory (RAIR). In the treatment cancer, tyrosine kinase inhibitors administered prevent growth...

introduction:  the use of radioactive iodine (131i) has become an important adjunct to the treatment of thyroid cancer and hyperthyroidism. salivary gland has the ability to concentrate radioactive iodine under normal circumstances. salivary gland dysfunction and dry mouth are the common side effectsof high-dose radioiodine therapy. the purposeof this study was to determine the absorbed dose of...

BACKGROUND Ablative radioiodine-131 ((131)I) therapy is used in the standart treatment procedure of thyroid carcinoma and procedures using (131)I represent the majority of Nuclear Medicine therapeutic procedures. The principal route of (131)I excretion after the administration of (131)I is the urine. Amifostine is an organic thiophosphate ester prodrug and the kidney concentrations of the activ...

  Introduction:  The use of radioactive iodine (131I) has become an important adjunct to the treatment of thyroid cancer and hyperthyroidism. Salivary gland has the ability to concentrate radioactive iodine under normal circumstances. Salivary gland dysfunction and dry mouth are the common side effectsof high-dose radioiodine therapy. The purposeof this stu...

To evaluate the effects of simple compensated fixed-dose iodine-131 therapy for thyrotoxicosis, the long-term results for 74 patients treated with a fixed dose of iodine-131 ranging from 5 to 12 mCi (185 to 444 MBq) were evaluated in the first 2 years of a trial. The dose selected was loosely based on the gross size of the thyroid gland. Routine antithyroid drug therapy was given for a minimum ...